Drug repositioning: Filling the gap

EBR - European Biopharmaceutical Review

Volumn , Issue SUMMER, 2010, Pages 44-48

  Insa, Raúl ^a  

^a SOM Biotech ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BOTULINUM TOXIN A; CYTOKINE; FINASTERIDE; GROWTH FACTOR; IMATINIB; IMMUNOMODULATING AGENT; MONOCLONAL ANTIBODY; RITUXIMAB; SILDENAFIL;

COMBINATORIAL CHEMISTRY; COMPUTER MODEL; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG INDUSTRY; DRUG REPOSITIONING; DRUG SAFETY; DRUG TREATMENT FAILURE; GENOMICS; HEALTH CARE PERSONNEL; HIGH THROUGHPUT SCREENING; LEGAL ASPECT; NONHUMAN; PATIENT COMPLIANCE; PROTEOMICS; SCREENING; SHORT SURVEY; STEM CELL TRANSPLANTATION;

EID: 77958198423     PISSN: 1364369X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (15)

1. Dimasi JA, Risks in new drug development: approval success rates for investigational drugs, Clin Pharmacol Ther 69(5): pp297-307, 2001
2. Reichert JM, Trends in development and approval times for new therapeutics in the United States, Nat Rev Drug Discovery 2(9): pp695-702, 2003
3. Reichert JM and Valge-Archer VE, Development trends for monoclonal antibody cancer therapeutics, Nature Reviews Drug Discovery 6(5): pp349-356, 2007
4. Chong CR and Sullivan Jr DJ, New uses for old drugs, Nature 448 (7,154): pp645-646, 2007
5. Tobinick EL, The value of drug repositioning in the current pharmaceutical market, Drug News Perspect 22(2): pp119-125, 2009
6. Tartaglia LA, Complementary new approaches enable repositioning of failed drug candidates, Expert Opin Investig Drugs 15(11): pp1,295-1,298, 2006
7. Campàs C, Drug repositioning summit: finding new routes to success, Drug News Perspect 22(2): pp126-128, 2009
8. Dubus E, Ijjaali I, Barberan O and Petitet F, Drug repositioning using in silico compound profiling, Future Med Chem 1(9): pp1,723-1,735, 2009
9. Schneider P, Tanrikulu Y and Schneider G, Self-organizing maps in drug discovery: compound library design, scaffold-hopping, repurposing, Current Medicinal Chemistry 16: pp258-266, 2009
10. Keiser MJ et al, Predicting new molecular targets for known drugs, Nature 08506: pp1-8, 2009
11. Sato T, Matsuo Y, Honma T and Yokoyama S, In silico functional profiling of small molecules and its applications, J Med Chem 51: pp7,705-7,716, 2008
12. Ashburn TT and Thor KB, Drug repositioning: identifying and developing new uses for existing drugs, Nature Reviews 3: pp673-683, 2004
13. Hunter J, Is open innovation the way forward for big pharma?, Nature Reviews 9: p87, 2010
14. Chong CR and Sullivan DJ, New uses for old drugs, Nature 448(9): pp645-646, 2007
15. Barton CL, Drug Repositioning Strategies, Innovative strategies to boost pipeline productivity, Business Insights Report, 2007